Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 8, 2025
Shareholder-Approved Merger with Verde Bioresins, Inc. Progressing Towards Close
GlobeNewswire
·
April 8, 2025
MESA, Ariz., April 08, 2025 (GLOBE NEWSWIRE) -- Nxu, Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company focused on energy storage and charging solutions for the infrastructure we need to power our electrified future, today announced …
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
GlobeNewswire
·
April 8, 2025
CORAL GABLES, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …
Ocugen to Present at the 2025 Cell & Gene Meeting on the Med
GlobeNewswire
·
April 8, 2025
MALVERN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer, …
PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 8, 2025
NCI presentation to highlight IL-12 fused antibody drug conjugate during poster presentation PRINCETON, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy …
NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting
GlobeNewswire
·
April 8, 2025
Three-year data from the largest FDA-reviewed prospective neuromodulation study of safety and effectiveness in drug-resistant focal epilepsy1 Long-term seizure reduction with a median reduction of 82% at 3 years. Seizure freedom with 42% of patients …
SCYNEXIS to Present Preclinical Data on Second Generation IV/Oral Fungerp SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
GlobeNewswire
·
April 8, 2025
JERSEY CITY, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of …
Aqua Security Achieves FedRAMP® High Authorization
GlobeNewswire
·
April 8, 2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- Aqua Security, the pioneer in cloud native security, announced today that it has achieved the Federal Risk and Authorization Management Program’s (FedRAMP®) high impact authorization status and is listed in the …
Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial
GlobeNewswire
·
April 8, 2025
MORRISVILLE, N.C., April 08, 2025 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, today announced the successful completion of its second FDA inspection, reaffirming the quality of its Direct-to-Patient Site for …
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session
GlobeNewswire
·
April 8, 2025
Analyses of MRI and VEP data confirm anatomical and physiological improvements, indicating remyelination and neuronal repair in the brains of MS patients treated with CNM-Au8 during the long-term extension of VISIONARY-MS Over 90% of participants who …
ProStar Announces Global Commercial Strategy with Radiodetection to Deliver Precision Utility Mapping
GlobeNewswire
·
April 8, 2025
GRAND JUNCTION, Colo., April 08, 2025 (GLOBE NEWSWIRE) -- ProStar® Holdings Inc., (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00) the developers of PointMan®, Precision Mapping Solutions® is pleased to announce a Global Commercial …
Melissa Celebrates 40th Anniversary as the Address Expert
GlobeNewswire
·
April 8, 2025
RANCHO SANTA MARGARITA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Celebrating an industry milestone, Melissa today announced its 40th anniversary as the Address Expert. The company is a global leader in data quality and address management solutions, and …
Regula Wins Gold in the Globee Awards for Cybersecurity for Its Complete Identity Verification Solution
GlobeNewswire
·
April 8, 2025
RESTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Regula, a global developer of forensic devices and identity verification (IDV) solutions, has received Gold in the 2025 Globee Awards for Cybersecurity. This marks Regula’s second consecutive year of winning …
LightSolver Appoints Former HSBC CEO Colin Bell to Advisory Board
GlobeNewswire
·
April 8, 2025
TEL AVIV, Israel, April 08, 2025 (GLOBE NEWSWIRE) -- LightSolver, inventor of a new laser-based computing paradigm, today announced the appointment of financial and banking expert Colin Bell to its Advisory Board. Bell will assist LightSolver with its go- …
Vivex Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
GlobeNewswire
·
April 8, 2025
MIAMI, April 08, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company has enrolled 50% of the patients in its ASCEND clinical trial for VIA Disc NPTM. The ASCEND study is a …
Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies
GlobeNewswire
·
April 8, 2025
BOSTON, April 08, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
GlobeNewswire
·
April 8, 2025
First pediatric patient shows encouraging early safety profile and meaningful improvement in visual function at one month A second pediatric patient was recently dosed, and the pediatric cohort is expected to complete enrollment in Q2 2025; initial data …
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
GlobeNewswire
·
April 8, 2025
SEATTLE, April 08, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …
Cycurion, Inc. Expands Partnership with Journal Technologies, Secures $22 Million Contract with State Police Agency
GlobeNewswire
·
April 8, 2025
FALLS CHURCH, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU), a trailblazer in advanced cybersecurity and information technology solutions, today announces an expanded partnership with Journal Technologies, a leading provider of case …
Recursion Announces First Patient Dosed in Phase 1 Clinical Study of REC-3565, a Selective MALT1 Inhibitor for Relapsed or Refractory B-cell Lymphomas
GlobeNewswire
·
April 8, 2025
Salt Lake City, UT, April 08, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that the first patient has been dosed in the Phase 1 EXCELERIZE clinical …
TransGlobal Assets Inc. (OTC: TMSH) Set to Transform Fintech and Dating with AI-Powered Platforms: Intelligent Debt Solutions and DateGuard
GlobeNewswire
·
April 8, 2025
AI-First Debt Solutions That Prioritize Human Wellness: Intelligent Debt Solutions leverages real-time behavioral analytics and ethical AI to offer highly personalized financial recovery pathways for individuals while boosting efficiency and empathy in …